Default company panoramic image
A08b6ebe 4d9e 4d66 9e79 48c9d8a6745f

Cypher Genomics

Cypher Genomics provides rapid and comprehensive annotation and analysis of genomic variants to turn genomic data into actionable knowledge.

  • Stage Product In Development
  • Industry Software
  • Location San Diego, CA, USA
  • Currency USD
  • Website

Company Summary

Cypher Genomics' advanced suite of analytical and visualization tools utilizes scientific, medical, and computational expertise to merge what is known about the human genome with sophisticated prediction algorithms in order to provide rapid and genuinely informative personalized genome annotations and transform an individual’s genome sequence into understandable and actionable information.


  • Default avatar
    Nicholas Schork
    President and CEO

    Dr. Schork is the Director of Research at the Scripps Translational Science Institute, and Professor, Molecular and Experimental Medicine at The Scripps Research Institute. Dr. Schork is a leading expert in quantitative human genetics and genomics and previously worked at Genset and has served on a number of Advisory boards.

  • Default avatar
    Ali Torkamani
    Chief Scientific Officer

    Dr. Torkamani is the Director of Drug Discovery at the Scripps Translational Science Institute and developed the initial version of the annotation pipeline. Dr. Torkamani is an expert in the field of mutation prediction and gene network analysis.

  • Default avatar
    Eric Topol
    Chief Medical Officer

    Dr. Topol is the Director of the Scripps Translational Science Institute and Chief Academic Officer of Scripps Health. Dr. Topol’s work in the genomics of heart disease has been recognized by the American Heart Association (top 10 advances 2002, 2004) and Time Magazine Medical Breakthrough of the Year in 2010. He has extensive experience in life science startups and is considered one the nation’s thought leaders in genomic medicine.

  • Default avatar
    Ashley Van Zeeland
    COO and CFO

    Dr. Van Zeeland is Director, Strategic Partnerships for Scripps Genomic Medicine. Dr. Van Zeeland is responsible for commercializing technology out of the Scripps Translational Science Institute and building public-private partnerships. She also has experience in clinical applications of DNA sequencing and building predictive models of disease.


  • Default avatar
    Noel Gillespie - Procopio